Leverage Shares 2X Long FIX Daily ETF (BATS:FIXX) CFO Sells 1,301 Shares of Company Stock

Leverage Shares 2X Long FIX Daily ETF (BATS:FIXX) CFO Lee Kalowski sold 1,301 shares of the firm’s stock in a transaction that occurred on Tuesday, October 6th. The stock was sold at an average price of $8.32, for a total transaction of $10,824.32. Following the sale, the chief financial officer directly owned 137,170 shares of the company’s stock, valued at approximately $1,141,254.40. This trade represents a 0.94% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Lee Kalowski also recently made the following trade(s):

• On Tuesday, August 25th, Lee Kalowski sold 3,972 shares of Leverage Shares 2X Long FIX Daily ETF stock. The shares were sold at an average price of $16.56, for a total transaction of $65,776.32.

Leverage Shares 2X Long FIX Daily ETF Stock Performance

BATS:FIXX traded down $1.35 during trading hours on Wednesday, reaching $11.01. The company had a trading volume of 2,492 shares, compared to its average volume of 2,920. Leverage Shares 2X Long FIX Daily ETF has a twelve month low of $11.00 and a twelve month high of $15.92.

Homology Medicines, Inc was a clinical-stage biotechnology company focused on developing genetic medicines for patients with rare diseases. The company sought to use its proprietary human-derived adeno-associated virus vectors, known as AAVHSCs, to deliver gene therapies in vivo and address the underlying causes of inherited disorders.

Its development programs included HMI-103, an investigational gene therapy for phenylketonuria, as well as earlier programs targeting other rare diseases.